Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-controlled, Double-blind Study of the Effect of Bondronat Compared With Zoledronic Acid on Pain in Patients With Malignant Bone Disease Experiencing Moderate to Severe Pain
Conditions
Interventions
ibandronate [Bondronat]
zoledronic acid
Locations
72
United States
Birmingham, Alabama, United States
Sedona, Arizona, United States
Ocoee, Florida, United States
Macon, Georgia, United States
Galesburg, Illinois, United States
Indianapolis, Indiana, United States
Start Date
July 1, 2005
Primary Completion Date
December 1, 2007
Completion Date
December 1, 2007
Last Updated
August 16, 2017
NCT07553000
NCT06382272
NCT06821607
NCT07231419
NCT07547774
NCT05883540
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions